Versartis, Inc. (VSAR) Saw a New 52-Week Low

Andrew Cummings
September 24, 2017

Versartis presently has a consensus rating of "Hold" and an average price target of $8.78.

ILLEGAL ACTIVITY NOTICE: "Versartis, Inc". Cantor Fitzgerald maintained the stock with "Buy" rating in Thursday, July 27 report. SunTrust initiated the stock with "Buy" rating in Friday, December 2 report. The firm has "Outperform" rating by Northland Capital given on Thursday, April 7.

Versartis, Inc. (NASDAQ:VSAR)'s stock had its "buy" rating reissued by equities research analysts at Piper Jaffray Companies in a research report issued on Friday, September 8th. The stock of Versartis Inc (NASDAQ:VSAR) earned "Buy" rating by SunTrust on Friday, December 2. The stock has "Equal Weight" rating by Morgan Stanley on Thursday, August 13. On Friday, May 26 the stock rating was maintained by Canaccord Genuity with "Buy". One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. Therefore 25% are positive. Accuray had 17 analyst reports since August 5, 2015 according to SRatingsIntel. Canaccord Genuity has "Buy" rating and $2800 target. The stock has "Neutral" rating by Piper Jaffray on Thursday, September 3.

On September 22 the company was downgraded to "Neutral" from " in a report from Barclays.

Among 12 analysts covering Versartis Inc (NASDAQ:VSAR), 7 have Buy rating, 1 Sell and 4 Hold. Finally, Zacks Investment Research upgraded Versartis from a "sell" rating to a "hold" rating in a research note on Wednesday, August 30th.

It closed at $4.45 lastly. Liberty Interactive Corporation - Series A Liberty Ventures (NASDAQ:LVNTA) has risen 51.21% since September 20, 2016 and is uptrending. It has underperformed by 43.57% the S&P500.

Accuray Incorporated is a radiation oncology company.

The stock is among the market's biggest losers today. The Company's products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform.

Investors sentiment increased to 2.27 in Q4 2016. Its down 0.11, from 1.21 in 2017Q1. It dropped, as 96 investors sold HAL shares while 307 reduced holdings. 30 funds opened positions while 55 raised stakes. Tower Research Capital Llc (Trc), New York-based fund reported 100 shares. Nationwide Fund Advisors has invested 0% in Versartis Inc (NASDAQ:VSAR). (HAL) stake by 9.11% reported in 2017Q2 SEC filing. Neuberger Berman Grp Lc owns 4.80 million shares. The Kingdon Capital Management Llc holds 117,043 shares with $2.04 million value, down from 372,069 last quarter. 11,327 were accumulated by Peak6 Invs Ltd Partnership. About 40.10M shares traded or 6569.49% up from the average. Fmr Ltd Liability Company reported 0.01% stake. Northern Trust holds 0% or 420,553 shares in its portfolio.

Versartis (NASDAQ:VSAR) last issued its quarterly earnings data on Thursday, July 27th. It has outperformed by 86.48% the S&P500.

Versartis, an endocrine-focused biopharmaceutical company. The company has market cap of $769.59 million. Development of the long-acting recombinant human growth hormone in pGHD was the only task listed in the "use of proceeds" section when Versartis pulled off an upsized $126 million IPO in 2014. I would like to thank the investigators, pediatric GHD patients and families that participated in the Velocity trial.

Investors sentiment decreased to 1.39 in Q2 2017. Its down 0.74, from 2.13 in 2017Q1. It dived, as 19 investors sold Versartis Inc shares while 19 reduced holdings. Proshare Limited Company has invested 0% of its portfolio in Versartis Inc (NASDAQ:VSAR). Manufacturers Life Ins Com The invested in 26,326 shares or 0% of the stock. Comml Bank Of Hawaii stated it has 32,935 shares or 0.12% of all its holdings. Tiaa Cref Mgmt Ltd Co has 288,960 shares. Baring Asset invested in 1.11% or 398,926 shares.

Wall Street await Versartis Inc (NASDAQ:VSAR) to release earnings on November, 2. Campbell Communications Adviser Limited Com, a Maryland-based fund reported 7,401 shares.

Other reports by iNewsToday